Jon G. Mabley
- Molecular Biology top 5%
- Oncology top 1%
- Physiology top 2%
- Immunology top 2%
- Cardiology and Cardiovascular Medicine top 2%
- Co-authors
- Csaba SzabóPál PacherLucas LiaudetFrancisco García SorianoGyörgy HaskóAndrew L. SalzmanLászló VirágAnita Marton
- Topics
- PARP inhibition in cancer therapy (27 papers)Pancreatic function and diabetes (13 papers)Adenosine and Purinergic Signaling (12 papers)
- Partner nations
- United StatesUnited KingdomHungary
In The Last Decade
Jon G. Mabley
85 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 119
- Molecular Biology 1.9k
- Oncology 1.8k
- Physiology 1.1k
- Immunology 1.1k
- Cardiology and Cardiovascular Medicine 1.1k
Countries citing papers authored by Jon G. Mabley
This map shows the geographic impact of Jon G. Mabley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon G. Mabley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon G. Mabley more than expected).
Fields of papers citing papers by Jon G. Mabley
This network shows the impact of papers produced by Jon G. Mabley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon G. Mabley. The network helps show where Jon G. Mabley may publish in the future.
Co-authorship network of co-authors of Jon G. Mabley
This figure shows the co-authorship network connecting the top 25 collaborators of Jon G. Mabley. A scholar is included among the top collaborators of Jon G. Mabley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon G. Mabley. Jon G. Mabley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 60 | |
| 3 | 76 | |
| 4 | 281 | |
| 5 | 68 | |
| 6 | 69 | |
| 7 | 64 | |
| 8 | 23 | |
| 9 | 80 | |
| 10 | 88 | |
| 11 | 174 | |
| 12 | 88 | |
| 13 | 158 | |
| 14 | 90 | |
| 15 | 29 | |
| 16 | 78 | |
| 17 | 280 | |
| 18 | 12 | |
| 19 | 54 | |
| 20 | 8 |
About Jon G. Mabley
Jon G. Mabley is a scholar working on Physiology, Oncology and Endocrine and Autonomic Systems, having authored 85 papers that have together received 6.7k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (27 papers), Pancreatic function and diabetes (13 papers) and Adenosine and Purinergic Signaling (12 papers). The work is most often cited by research in Physiology (1.0k citations), Oncology (1.8k citations) and Clinical Biochemistry (375 citations). Jon G. Mabley has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Csaba Szabó, Pál Pacher, Lucas Liaudet, Francisco García Soriano, György Haskó, Andrew L. Salzman, László Virág, Anita Marton, Garry J. Southan and Éva Szabó. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.